Paper Details

  1. Home
  2. Paper Details

Neoadjuvant chemotherapy before surgery versus surgery followed by chemotherapy for initial treatment in advanced ovarian epithelial cancer.

Author: BryantAndrew, ColeridgeSarah L, KehoeSean, MorrisonJo

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Meta-AnalysisA statistical technique that integrates the results of multiple studies to draw more general conclusions about a particular issue.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Overview

Most women with ovarian cancer are diagnosed at a late stage, needing both surgery and chemotherapy. The usual approach is surgery first, then chemotherapy, but giving chemotherapy before surgery might have benefits.
Paper Details　
Original Abstract of the Article :
Epithelial ovarian cancer presents at an advanced stage in the majority of women. These women require a combination of surgery and chemotherapy for optimal treatment. Conventional treatment has been to perform surgery first and then give chemotherapy. However, there may be advantages to using chemot...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406953/

データ提供：米国国立医学図書館（NLM）

A New Strategy for Combating Ovarian Cancer: Neoadjuvant Chemotherapy

The battle against ovarian cancer is a complex and challenging one, often involving a combination of surgery and chemotherapy. This study explores the potential benefits of using chemotherapy before surgery (neoadjuvant chemotherapy) for treating advanced epithelial ovarian cancer. The authors present a compelling argument for this approach, highlighting its potential to improve treatment outcomes for patients.

Neoadjuvant Chemotherapy: A New Approach

The study proposes neoadjuvant chemotherapy as a promising strategy for tackling advanced ovarian cancer. Imagine a traveler crossing a vast and arid desert, carefully planning their journey to reach a life-sustaining oasis. Similarly, by strategically using chemotherapy before surgery, clinicians could potentially create a more favorable environment for successful treatment.

Hope for Improved Outcomes

The authors suggest that neoadjuvant chemotherapy could offer several advantages, including a better chance of achieving complete tumor removal and potentially improving survival rates. This research represents a significant step forward in the fight against ovarian cancer, offering a new avenue for potentially improving outcomes for patients.

Dr.Camel's Conclusion

The journey with ovarian cancer can be a daunting one, like traversing a vast and unforgiving desert. This study offers a beacon of hope, highlighting the potential benefits of neoadjuvant chemotherapy. By exploring new and innovative approaches, we can strive to create more effective treatment strategies and ultimately improve the lives of patients facing this challenging disease.

Date :
  1. Date Completed 2021-08-12
  2. Date Revised 2022-07-31
Further Info :

Pubmed ID

34328210

DOI: Digital Object Identifier

PMC8406953

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.